Thoracic endovascular aortic repair for type B aortic dissection patients: 11-year experience from a Chinese Tertiary Center  

作　　者：Yuan-Qing Kan Da-Qiao Guo Yi Si Wei-Guo Fu 

机构地区：[1]Department of Vascular Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China.

出　　处：《Chinese Medical Journal》2021年第8期971-972,共2页中华医学杂志（英文版）

基　　金：a grant from the National Natural Science Foundation of China(No.82070497).

摘　　要：Thoracic endovascular aortic repair(TEVAR)has been gradually considered as the mainstream therapy for type B aortic dissection(TBAD),especially for complicated acute TBAD,[1]due to its minimally invasive nature and satisfactory clinical outcomes.Currently,our knowledge of aortic dissection and endovascular treatment is primarily derived from western registries including the International Registry of Acute Aortic Dissection(IRAD)and Vascular Quality Initiative(VQI),which includes few Asian TBAD patients without any Chinese population.Therefore,we report a long-term single-center experience of TBAD patients who underwent TEVAR in a Chinese high-volume tertiary center.The preliminary results would provide useful insight and enhances our understanding of this disease in the Chinese population.

关 键 词：DISSECTION PATIENTS AORTIC 

分 类 号：R543.1[医药卫生—心血管疾病]